Consequences of Tariffs on Pharmaceutical Products

That is the topic of a JMCP Viewpoint by Sean Sullivan, Jens Grueger, Aidan Sullivan, and Scott Ramsey. Some excerpts: The Budget Lab at Yale University projected that a 25% ad valorem tariff would increase medication costs by an “average of around $600 per year per household in the United States.”3 Tariffs can also create supply…

Read More

Innovation: How can we quantify it?

In the HEOR world, you hear a lot about innovation. However, how can we measure innovation? The easiest way is to count the number of new drugs. However, ten “me too” products may be considered less innovative than a single product that cures a disease. An essay by Sukhun Kang in The Incidental Economist conducted…

Read More